Constitutional Megaloblastic Anemia with Severe Neurologic Disease (DHFR Deficiency)

Constitutional Megaloblastic Anemia with Severe Neurologic Disease, commonly known as DHFR deficiency, is an ultra-rare genetic condition that fundamentally changes how the body manages one of its most essential nutrients: folate (Vitamin B9). In a healthy body, folate is constantly processed by an enzyme called dihydrofolate reductase (DHFR), allowing cells to build DNA and support the nervous system. In children with this condition, the DHFR gene contains pathogenic variants that cause this metabolic machinery to break down, leaving the body with a critical shortage of the active folate it needs to function ^[1].

This biological disruption primarily impacts two areas of the body that are most sensitive to folate levels: the bone marrow and the brain. In the blood, this manifests as megaloblastic anemia, where the body produces unusually large and immature red blood cells that cannot properly carry out their work. In the brain, the lack of active folate can lead to significant neurological challenges, including seizures and developmental delays that often appear early in life ^[1][2]. Because these symptoms can look very similar to more common Vitamin B12 deficiencies, an accurate diagnosis is vital. This relies on specialized genetic testing alongside the measurement of specific metabolic markers—such as homocysteine and methylmalonic acid (MMA)—to help distinguish a folate pathway defect from a cobalamin (B12) processing disorder ^[3].

Managing DHFR deficiency involves using specific forms of reduced folate supplementation (such as folinic acid/leucovorin) to bypass the broken enzyme and provide the body with the “ready-to-use” nutrients it is missing. While these specialized treatments can lead to improvements in blood counts and neurological stability for some patients, the condition remains complex and outcomes can be unpredictable. Rarity means that your family will work closely with a specialized team of metabolic geneticists, hematologists, and neurologists who monitor your child’s health with great care ^[1]. Though the journey of navigating an ultra-rare diagnosis is challenging, understanding the underlying biology of the condition empowers you to be an active partner in your child’s specialized care and long-term development.